Lauer Wealth LLC Sells 2,116 Shares of CVS Health Co. (NYSE:CVS)

Lauer Wealth LLC decreased its position in CVS Health Co. (NYSE:CVS) by 26.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,003 shares of the pharmacy operator’s stock after selling 2,116 shares during the period. CVS Health makes up about 0.3% of Lauer Wealth LLC’s portfolio, making the stock its 25th biggest holding. Lauer Wealth LLC’s holdings in CVS Health were worth $377,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Crewe Advisors LLC acquired a new position in CVS Health in the 1st quarter worth about $40,000. Retirement Group LLC lifted its holdings in CVS Health by 54.3% during the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 182 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health during the third quarter worth approximately $33,000. Finally, First Community Trust NA lifted its position in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

NYSE:CVS traded up $0.87 on Monday, reaching $57.36. The stock had a trading volume of 1,893,336 shares, compared to its average volume of 11,179,563. The stock has a fifty day moving average price of $59.82 and a 200-day moving average price of $59.84. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The company has a market capitalization of $72.01 billion, a P/E ratio of 9.93, a price-to-earnings-growth ratio of 0.84 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $2.21 earnings per share. Research analysts forecast that CVS Health Co. will post 6.41 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.64%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is 46.75%.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday. Deutsche Bank Aktiengesellschaft cut their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Barclays decreased their target price on CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a research report on Wednesday, October 23rd. Finally, Evercore ISI boosted their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $74.58.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.